| Oct-15 |
Crescent Biopharma Announces Clinical Pipeline Momentum, including Enrolling Patients in Standard of Care Chemotherapy Combination Cohorts of Global Phase 1/2 ASCEND Trial of CR-001, a PD-1 x VEGF Bispecific Antibody, and Initiation of Additional ADC Combination Studies with CR-001
CBIO CBIO -5.13%
GlobeNewswire
|
| Oct-06 | |
| Oct-05 | |
| Sep-25 | |
| Sep-09 | |
| Sep-03 | |
| Aug-03 | |
| Jul-30 | |
| Jul-23 | |
| Jul-16 | |
| Jul-14 | |
| Jul-14 | |
| Jun-26 | |
| Jun-11 | |
| Jun-02 | |
| May-29 | |
| May-21 | |
| May-12 | |
| May-06 | |
| Apr-29 | |
| Apr-24 | |
| Mar-27 | |
| Mar-06 | |
| Feb-26 | |
| Feb-23 | |
| Feb-19 | |
| Feb-18 | |
| Feb-05 | |
| Jan-30 | |
| Jan-05 | |
| Dec-18 | |
| Dec-04 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite